SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,162,000 | -74.2% | 199,945 | -66.8% | 0.01% | -75.0% |
Q4 2021 | $4,511,000 | -18.0% | 601,521 | -1.5% | 0.02% | -17.2% |
Q3 2021 | $5,501,000 | -24.2% | 610,590 | +0.8% | 0.03% | -25.6% |
Q2 2021 | $7,253,000 | -8.9% | 605,897 | -4.7% | 0.04% | -13.3% |
Q1 2021 | $7,964,000 | -21.8% | 635,568 | -2.6% | 0.04% | -25.0% |
Q4 2020 | $10,183,000 | +122.1% | 652,531 | +34.5% | 0.06% | +106.9% |
Q3 2020 | $4,584,000 | +9.5% | 485,042 | +3.8% | 0.03% | +7.4% |
Q2 2020 | $4,185,000 | +81.1% | 467,087 | +28.8% | 0.03% | +68.8% |
Q1 2020 | $2,311,000 | +64.4% | 362,761 | +115.9% | 0.02% | +166.7% |
Q4 2019 | $1,406,000 | +5758.3% | 168,003 | +6138.5% | 0.01% | – |
Q2 2017 | $24,000 | -11.1% | 2,693 | -39.7% | 0.00% | – |
Q1 2016 | $27,000 | -34.1% | 4,469 | 0.0% | 0.00% | – |
Q4 2015 | $41,000 | +86.4% | 4,469 | +12.5% | 0.00% | – |
Q3 2015 | $22,000 | -89.1% | 3,972 | -69.0% | 0.00% | -100.0% |
Q1 2015 | $201,000 | – | 12,828 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |